[go: up one dir, main page]

WO1995018600A1 - Composition dermatologique a base de crotamiton et d'au moins un antiseptique cationique - Google Patents

Composition dermatologique a base de crotamiton et d'au moins un antiseptique cationique Download PDF

Info

Publication number
WO1995018600A1
WO1995018600A1 PCT/FR1995/000001 FR9500001W WO9518600A1 WO 1995018600 A1 WO1995018600 A1 WO 1995018600A1 FR 9500001 W FR9500001 W FR 9500001W WO 9518600 A1 WO9518600 A1 WO 9518600A1
Authority
WO
WIPO (PCT)
Prior art keywords
crotamiton
composition based
cationic antiseptic
dermatological composition
dermatological
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/FR1995/000001
Other languages
English (en)
Inventor
Isabelle Lagarde
Emmanuelle Couval
Roger Navarro
Michel Jeanjean
Dominique Toselli
Eric Gooris
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre Dermo Cosmetique SA
Original Assignee
Pierre Fabre Dermo Cosmetique SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre Dermo Cosmetique SA filed Critical Pierre Fabre Dermo Cosmetique SA
Publication of WO1995018600A1 publication Critical patent/WO1995018600A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A61K8/416—Quaternary ammonium compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42—Amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/43—Guanidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)

Abstract

La présente invention concerne une composition dermatologique et/ou cosmétologique, caractérisée en ce qu'elle contient du crotamiton en association avec au moins un antiseptique cationique choisi dans le groupe comprenant les sels pharmaceutiquement acceptables d'ammonium quaternaires, de benzalkonium, d'hexamidine, ou de chlorhexidine. Elle concerne également son utilisation pour la préparation d'un médicament.
PCT/FR1995/000001 1994-01-03 1995-01-02 Composition dermatologique a base de crotamiton et d'au moins un antiseptique cationique Ceased WO1995018600A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR94/00009 1994-01-03
FR9400009A FR2714603B1 (fr) 1994-01-03 1994-01-03 Composition dermatologique et son utilisation pour la préparation d'un médicament.

Publications (1)

Publication Number Publication Date
WO1995018600A1 true WO1995018600A1 (fr) 1995-07-13

Family

ID=9458760

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR1995/000001 Ceased WO1995018600A1 (fr) 1994-01-03 1995-01-02 Composition dermatologique a base de crotamiton et d'au moins un antiseptique cationique

Country Status (2)

Country Link
FR (1) FR2714603B1 (fr)
WO (1) WO1995018600A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8063097B2 (en) 2003-04-17 2011-11-22 The Procter & Gamble Company Compositions and methods for regulating mammalian keratinous tissue

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6803496B2 (en) 1997-09-10 2004-10-12 The Procter & Gamble Company Method for maintaining or improving skin health
US6703536B2 (en) 1998-03-12 2004-03-09 The Procter & Gamble Company Disposable absorbent article having a skin care composition containing an enzyme inhibitor
TR200002602T2 (tr) 1998-03-12 2001-02-21 The Proctor & Gamble Company Emici eşaylarda proteaz inhibitörleri.
US6207596B1 (en) 1998-11-09 2001-03-27 The Procter & Gamble Company Disposable premoistened wipe containing an antimicrobial protease inhibitor
FR2793680B1 (fr) * 1999-04-26 2002-08-02 Oreal Utilisation de composes antifongiques halogenes et de composes antibacteriens cationiques pour traiter les rougeurs cutanees et/ou les desordres desquamatifs lies a malassezia spp
US6570054B1 (en) 1999-05-21 2003-05-27 The Procter & Gamble Company Absorbent article having a stable skin care composition
AU4858300A (en) 1999-05-21 2000-12-12 Procter & Gamble Company, The Absorbent article having a skin care composition

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6115845A (ja) * 1984-06-29 1986-01-23 Hisamitsu Pharmaceut Co Inc シエラツク含有外皮用組成物
JPH0344322A (ja) * 1989-07-13 1991-02-26 Shiseido Co Ltd マイクロエマルション製剤及びその製造法
EP0521455A2 (fr) * 1991-07-02 1993-01-07 Takeda Chemical Industries, Ltd. Composition d'aérosol contenant un polymère d'acide hydroxycarboxylique filmogène

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6115845A (ja) * 1984-06-29 1986-01-23 Hisamitsu Pharmaceut Co Inc シエラツク含有外皮用組成物
JPH0344322A (ja) * 1989-07-13 1991-02-26 Shiseido Co Ltd マイクロエマルション製剤及びその製造法
EP0521455A2 (fr) * 1991-07-02 1993-01-07 Takeda Chemical Industries, Ltd. Composition d'aérosol contenant un polymère d'acide hydroxycarboxylique filmogène

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CHEMICAL ABSTRACTS, vol. 104, no. 20, 19 May 1986, Columbus, Ohio, US; abstract no. 174709, AKIRA N. ET AL: "Shellac containing film forming compositions for wound healing and as topical pharmaceuticals" *
DATABASE WPI Section Ch Week 9114, Derwent World Patents Index; Class A12, AN 91-099139 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8063097B2 (en) 2003-04-17 2011-11-22 The Procter & Gamble Company Compositions and methods for regulating mammalian keratinous tissue

Also Published As

Publication number Publication date
FR2714603A1 (fr) 1995-07-07
FR2714603B1 (fr) 1996-03-22

Similar Documents

Publication Publication Date Title
AU1808595A (en) 3,8-diazabicyclo{3.2.1}octane derivatives having analgesic activity
CA2163003A1 (fr) Agent de solubilisation et preparation a usage externe a base de cet agent
CA2180554A1 (fr) Conservation de compositions de medicaments ophtalmiques contenant des composes d'ammonium quaternaire polymere
MA26456A1 (fr) Formulations pharmaceutiques pour la distribution prolongee de medicament.
CA2194167A1 (fr) Produit stimulant la pousse des cheveux
NZ329184A (en) Delivery device for mixing and/or topically applying two compositions, one containing an active compound and the other containing a skin permeation enhancer
HUP9601566A3 (en) Therapeutic tetrahydro-isoquinolin derivatives, their intermediates and pharmaceutical compositions containing the active component
EE200000253A (et) Seentevastase toimeaine kasutamine ravimite valmistamiseks, mis on ette nähtud mitteinvasiivsetest seenorganismidest tingitud haiguste raviks või vältimiseks
ZA964873B (en) Tricot-like pouch for the delivery of topical drugs and cosmetics.
AU3076700A (en) 2h-phthalazin-1-one derivatives and drugs comprising these derivatives as the active ingredient
CA2332521A1 (fr) Composition pharmaceutique destinee a traiter ou prevenir les troubles du sommeil
ZA972147B (en) Dimethyl-(3-aryl-but-3-enyl)-amine compounds as pharmaceutical active ingredients.
NZ334124A (en) Use of the chelating agent clioquinol, with vitamin B12 for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease
TR199600873A2 (tr) Ikame edilmis sülfonimidamid'ler, bunlarin imal edilmesine mahsus usul, bunlarin ilac ya da diyagnoz maddesi olarak kullanilmalari ve ayrica bunlari ihtiva eden ilaclar.
FI961437L (fi) Vaikuttavan aineen luovuttava systeemi
HK1045113A1 (zh) 給予固定的曲馬朵和雙氯酚酸組合的口服給藥形式
PT1071433E (pt) 2',2'-difluoronuecleosidos para terapia imunossupressora e preparados farmaceuticos combinados
ZA200007415B (en) Amino acid derivatives and drugs containing the same as the active ingredient.
EP0960885A4 (fr) Depsipeptides et medicaments contenant ces composes comme ingredient actif
WO1995018600A1 (fr) Composition dermatologique a base de crotamiton et d'au moins un antiseptique cationique
AU1650501A (en) 1,3,4-oxadiazoline derivatives and drugs containing these derivatives as the active ingredient
CA2217513A1 (fr) Agents pharmaceutiques pour le traitement de la maladie d'alzheimer
IL108651A0 (en) 3-isothiazolones, their preparation and their use as antimicrobial agents
WO1998022099A3 (fr) Nouvelle utilisation de la creatine
WO1997005864A3 (fr) Utilisation de la l-cartinine et de ses derives dans le but de reduire les niveaux de ceramides et de potentialiser l'effet antiretroviral

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): CA JP US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: CA